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The basic helix-loop-helix transcription factor gene Hand1 has been implicated in development of the heart. However,
the early lethality of Hand1-null mutant mouse embryos has precluded a precise understanding of its function. In this
study, we have generated Hand1 homozygous mutant ES cells and performed in vitro differentiation experiments and
chimeric analysis to study the role of Hand1 function during cardiac development. Hand1-null ES cells were able to
differentiate into beating cardiomyocytes in vitro that expressed cardiac myosin and several cardiac-specific transcripts
ncluding Nkx2-5, a-cardiac actin, and the myofilament genes myosin light chain 2a and 2v. In chimeras derived from
and1-null ES cells and ROSA26 embryos, mutant cells were underrepresented in the left caudal region of the linear
eart tube at E8.0. By E9.5, after cardiac looping, mutant cells were underrepresented in the anterior region of the outer
urvature of the left ventricular myocardium, but did contribute to other parts of the left ventricle and to other cardiac
hambers. These results imply that Hand1 is not essential for differentiation of ventricular cardiomyocytes.
and1-null cells were also underrepresented in several other regions of later embryos, including the rhombencephalic
eural tube that was associated with a deficiency of mutant cells in the neural crest cell-derived cardiac outflow tract
nd first branchial arch. In summary, Hand1 has cell-autonomous functions during cardiac morphogenesis in both
esodermal and neural crest derivatives. © 2000 Academic Presst
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eINTRODUCTION
The heart is the first fetal organ to form during embryo-
genesis and perturbations in its development are mani-
fested as congenital cardiovascular anomalies that account
for 1% of all human birth defects (Olson and Srivastava,
1996). The vertebrate heart arises from mesoderm progeni-
tors that migrate to the anterior lateral aspect of the embryo
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Health, 30 Guilford Street, London WC1N 1EH, United Kingdom.
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O
rive, N.W., Calgary, Alberta T2N 4N1, Canada. Fax: (403) 270
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156o form paired cardiac primordia. These primordia cytodif-
erentiate and fuse at the midline to form the linear heart
ube, which begins to beat rhythmically, from the posterior
nd, at around embryonic day 8 (E8) in the mouse and day
3 in humans (DeRuiter et al., 1992; Olson and Srivastava,
996). Cell fate analyses demonstrated that the linear heart
ube is patterned along the anterior–posterior (A/P) axis into
egments that give rise to the aortic sac, cardiac outflow
ract, right ventricle, left ventricle, and atria (Yutzey and
ader, 1995). The heart tube then undergoes rightward
ooping which converts the A/P patterning into a left–right
L/R) orientation; the first morphological signs of L/R
symmetry in the vertebrate embryo. Cardiac looping is
onserved across all vertebrate species and is critical to
nsure correct chamber specification and alignment of the
reat vessels and outflow tract of the heart (Srivastava and
lson, 1997).
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157Role of Hand1 in Cardiac MorphogenesisA number of genes are required for early cardiac develop-
FIG. 1. Hand1 gene targeting and screening strategy. (A) Map of
separately target both alleles. The wild-type Hand1 gene consists o
is shaded, basic helix-loop-helix domain is shown in black) separate
et al., 1998). The puro targeting vector includes a 6.0-kb arm, whic
kb, which starts downstream of the exon 1–intron boundary. The
for homologous recombination events are shown. (B) Screening of H
cell genomic DNA was probed with a 1.6-kb 59 flanking probe (PstI/
band in R1 ES cells (129), the wild-type band plus lower band fro
wild-type allele in correctly targeted homozygous mutant lines (6.ment: the homeodomain protein Nkx2-5 (Lyons et al.,
1995), the MADS box transcription factor Mef2c (Lin et al.,
h
o
extends out from the midline, shows no L/R asymmetry, and is thin w
is outlined by red arrowheads.
Copyright © 2000 by Academic Press. All right997), and two related members of the basic helix-loop-
and1 locus and the neo and puro gene targeting vectors used to
exons (boxes: noncoding regions indicated in white, coding region
a 1.5-kb intron. The neo targeting vector has been described (Riley
resents a region 59 of the translation start site, and a 39 arm of 2.1
ions of the 59 flanking probe and PCR primer pairs used to screen
1-null mutant ES cells by Southern blot analysis. BglII-digested ES
fragment of the Hand1 gene). This probe revealed a 13-kb wild-type
e neo allele in the heterozygous cell line (14A3), and loss of the
.22).the H
f two
d by
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posit
andelix (bHLH) family of transcription factors. Hand1 (previ-
usly known as Hxt, eHAND, and Thing1) and Hand2FIG. 2. Cardiomyocyte differentiation in Hand1-null cells. (A) Control (1/2; 6.39) or Hand1 homozygous mutant (2/2; 6.13) ES cells
were differentiated in vitro as floating embryoid bodies for 14 days. Bodies were sectioned and stained with H&E. Note the extensive
avitation in embryoid bodies from both control (6.39) and mutant (6.13) cell lines. (B) Hand1-null embryoid bodies express myosin heavy
chain protein. Hand1 homozygous mutant (lines 6.13, 6.22) and heterozygous control, containing a single-copy random insertion of the
puromycin targeting vector (lines 5.13, 6.39), ES cells were allowed to differentiate as floating embryoid bodies for 10 days. Beating bodies
were first observed in both the mutant and the control lines by day 8 of culture. Sections through day 10 bodies were stained with the
monoclonal anti-myosin antibody MF20. Myosin protein was detected in both mutant and control lines in approximately 35% of bodies.
Staining was either punctate, localized to small numbers of foci (5.13, 6.22), or more diffuse, detectable in a larger number of myocytes (6.39,
6.13). (C) Comparative RT-PCR analysis of cardiac-specific gene expression in Hand1 heterozygous and homozygous mutant embryoid
bodies. Embryonic stem cells either heterozygous (1/2; line 14A3) or homozygous (2/2; lines 6.13 and 6.22) for the Hand1 allele, or
heterozygous and containing a random insertion of the puro targeting construct (line 1.22), were allowed to differentiate in vitro as floating
bodies for 4 days and then plated onto tissue culture dishes to facilitate differentiation for a further 10 days. RNA was harvested on days
4, 8, 12, and 16 for RT-PCR analysis. Adult mouse heart (H) and day 10.5 placenta (P) were used as control tissues. Primers specific for
Hand1, Nkx2-5, a-cardiac actin (aCA), myosin light chains (MLC) 2a and 2v, atrial natriuretic factor (ANF), smooth muscle 22 a (SM22a),
the neuregulin receptors ErbB2 and ErbB4, and b-actin were used (see Materials and Methods).
IG. 3. Chimeras with high Hand1-null cell contribution resemble Hand1 mutant and tetraploid-rescued Hand1-null embryos.
ggregation chimeras were produced from diploid ROSA26 (Freidrich and Soriano, 1991) embryos and Hand1-null ES cells. Embryos were
issected at E8.5 and E10.5, fixed, and stained for b-galactosidase activity. In the resulting chimeras blue cells are wild type and white cells
are Hand1 homozygous mutant. (A–C) E8.5 chimeras with high mutant ES cell contribution (.70%) phenocopy Hand1 mutants derived
from mating of heterozygous mice (Riley et al., 1998). Hand1-null embryos (A, B) and high ES cell contribution chimeras (C) fail to turn
and as a result the visceral yolk sac (ys) has not pulled around the embryo (A, C). The high ES cell contribution chimera (C) is shown with
extraembryonic membranes intact, including the ectoplacental cone (epc), to highlight the hemorrhagic yolk sac. Removal of the
extraembryonic membranes reveals a midline containing 8–10 somites (A, B). Red arrowheads highlight a primitive linear heart tube and
yellow arrowheads highlight head folds indicative of delayed neural tube closure. (D–F) Chimeric embryo dissected at E10.5 with
approximately 60% mutant cell contribution and an unlooped heart observed from the right (D), ventral (E), and left (F) sides. The heart tubealled. A small patch of wild-type cells, restricted to the right side,
s of reproduction in any form reserved.
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160 Riley et al.(previously known as Hed, dHAND, and Thing2) are ex-
pressed in early cardiac progenitors and in later embryonic
stages in the outflow tract and asymmetrically in the left
(systemic) and right (pulmonary) ventricles, respectively
(Cross et al., 1995; Cserjesi et al., 1995; Srivastava et al.,
1995; Hollenberg et al., 1995). Deletion of Hand2 in mice
results in a heart that lacks a right (pulmonary) ventricle
(Srivistava et al., 1997). In Hand2/inv double mutant mice,
in which the direction of heart looping in reversed, the
left-sided, pulmonary ventricle is hypoplastic, suggesting
that Hand2 may specify chamber identity and not laterality
per se (Thomas et al., 1998). The mechanisms that underlie
chamber specification are unknown. The existing model,
however, does suggest that Hand1 alternatively might
specify the systemic (normally the left) ventricle (Srivas-
tava, 1999). Mutation of the Hand1 gene demonstrates that
it has critical roles in development, which are distinct from,
and act earlier than, Hand2. Hand1-null embryos arrest
early in development due to extraembryonic defects (Firulli
et al., 1998; Riley et al., 1998; Scott et al., 2000), which
preclude analysis of cardiac functions. The Hand1-null
embryos can be rescued beyond this early embryonic lethal-
ity by aggregation with tetraploid blastomeres. However,
these embryos arrest at around E10 of development and
have unlooped and apparently unsegmented heart tubes
(Riley et al., 1998). In addition, these embryos present with
a thin ventricular wall and down-regulation of the
ventricular-specific myofilament gene MLC2v (Riley et al.,
1998; Firulli et al., 1998). All of these features resemble the
henotype of Nkx2-5 mutants (Lyons et al., 1995). The fact
hat the heart tubes in Hand1 mutants block at a primitive
nlooped stage implies a defect(s) more complex than
imply lacking a left ventricle, as has been suggested
Thomas et al., 1998).
The complicated Hand1 phenotype does not yield obvi-
us clues as to primary function(s) of Hand1 in cardiac
evelopment. For example, the myocardial defects sug-
ested that Hand1 could have a primary role in cardiomy-
cyte differentiation, and the failure to loop could simply be
FIG. 4. Heart looping in low to moderate ES cell contribution chi
he heart tube and location of presumptive right (RV) and left (LV
whole-mount in situ hybridization. The yellow arrow demarcates
demarcate the posterior and anterior regions of the central heart
respectively. Note that Hand1 expression is detected on both the
moderate mutant ES cell contribution chimeric embryo at E8.0, w
The heart from the chimera shown in C is viewed from the ventral (
(F) and left (G) side. Note the relative increased frequency of wild-
compared with the prominent patch of mutant cells on the anteri
heart tube and location of presumptive right and left ventricles at
in situ hybridization of dissected hearts. Note the anterior orientati
ace of the LV (J). (K) A low-magnification view of a low ES cell co
issected hearts from two examples of E8.5 chimeras viewed from
. Note the relative increased proportion of wild-type cells in the left v
t, outflow tract.
Copyright © 2000 by Academic Press. All rightconsequence of this. Alternatively, the failure of the
earts to loop could reflect a role for Hand1 in morphogen-
sis. Hand1 has been previously proposed as a mediator of
/R signaling and a direct regulator of the looping process,
ased upon the finding of asymmetrical Hand1 expression,
n both the mouse and the frog, at the late linear heart tube
tage (Biben and Harvey, 1997; Sparrow et al., 1998). Later
and1 expression is restricted to the outer curvature of the
resumptive left ventricle, a region that is thought to be the
eading edge of the looping heart tube (Taber et al., 1995;
iben and Harvey, 1997). In this study we set out to clarify
he function of Hand1 during cardiac development, by
studying the fate of Hand1-null ES cells in vitro and in
chimeric embryos.
MATERIALS AND METHODS
Generation of Hand1 homozygous mutant ES cell lines.
Hand1-null ES cell lines were generated by targeting the 14A3
Hand1 heterozygous cell line (Riley et al., 1998; Fig. 1A) using a
different selection marker, the puromycin-resistance gene
(PGKpuror). A 400-bp fragment upstream of the transcription start
ite (identified by primer extension analysis; data not shown) was
solated by PCR (primers: sense, 59-gaagatctctcttgaaggtttctg-39;
ntisense, 59-ttgtaaaacgacggccagtgaatt-39). This fragment was
loned upstream of the luciferase gene in the plasmid pGL2-basic
Promega). Distal 59 promoter sequences were ligated upstream of
he proximal promoter, producing a 6.0-kb 59 arm in the targeting
ector. The puror gene and a 2.0-kb 39 SalI/XhoI fragment from the
and1 gene were ligated downstream of luciferase (Fig. 1A). The
onstruct was linearized by digestion with KpnI and electroporated
nto the 14A3 cell line. Cells were selected in the presence of both
418 (0.15 mg/ml) and puromycin (1.5 mg/ml) in order to maximize
he chances of obtaining clones in which the wild-type copy, rather
han the Hand1neo allele, was mutated. Clones were screened for
homologous recombination by Southern blot analysis (Fig. 1B).
Embryoid bodies. ES cells were maintained in culture as de-
scribed previously (Wurst and Joyner, 1993). Cells at approximately
80% confluence were trypsinized and harvested in differentiation
medium (ES cell medium without leukemia inhibitory factor; LIF).
s at E8.0 to 8.5. (A) Diagram of anterior-to-posterior orientation of
tricles at E8.0. (B) Hand1 mRNA expression in E8.0 detected by
idline and orientation of the heart tube. Blue and red arrowheads
regions, representing the presumptive left and right ventricles,
and the left sides of the linear tube at E8.0. (C) A representative
unlooped heart. (D–G) Dissected hearts from two E8.0 chimeras.
d left (E) side. A different chimeric heart is shown from the anterior
(blue) cells on the left caudal side of the heart tubes (arrowheads),
t side shown in (F). (H) Diagram of left-to-right orientation of the
. (I, J) Hand1 mRNA expression at E8.5 detected by whole-mount
the heart tube revealing stronger Hand1 expression on the anterior
ution chimeric embryo with normally looped heart at E8.5. (L, M)
anterior surface; M shows the dissected heart from the embryo inmera
) ven
the m
tube
right
ith an
D) an
type
or lef
E8.5
on of
ntrib
the
entricle, compared to other regions of the heart. lv, left ventricle;
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161Role of Hand1 in Cardiac MorphogenesisCells were then transferred to 100-mm noncoated bacteriological
dishes (Fisher) at low density (’106 cells) to avoid the formation of
ggregates. After 4 days, differentiating cells were either main-
ained in floating culture for subsequent histological examination
r transferred to 100-mm tissue culture dishes (Falcon) coated with
.1% gelatin, allowed to adhere and differentiate for up to a further
2 days. After 10 days, approximately 20% of both floating and
dherent cultures contained beating foci. RNA was isolated from
dherent cultures after 4, 8, 12, and 16 days of differentiation for
se in reverse transcriptase-PCR (RT-PCR) assay to analyze
ardiac-specific gene expression. Floating embryoid bodies were
arvested after 10 and 14 days of culture, washed twice in PBS, and
xed in 10% formaldehyde for 1 h at room temperature. Fixed
odies were embedded in paraffin and 7-mm sections were stained
with 0.1% hematoxylin and 0.5% eosin (H&E).
Immunostaining. Floating embryoid bodies were differentiated
for either 10 or 14 days in vitro and then sampled for cryosectioning
and immunostaining. Bodies were harvested, washed twice with
PBS, and fixed in either 2 or 4% paraformaldehyde or 100%
methanol for 1 h at room temperature. After being rinsed twice in
PBS the bodies were transferred to 20% sucrose (in PBS) and rocked
overnight at 4°C. A further overnight incubation at 4°C was carried
out in 50:50 (v/v) 20% sucrose:OCT (Tissue-Tek) prior to embed-
ding in OCT and storage at 270°C. Sections (10 mm) were subjected
to indirect immunofluorescence using a monoclonal antibody
against cardiac myosin, MF20 (1:10; Developmental Studies Hy-
bridoma Bank; Bader et al., 1982) followed by an anti-mouse-
TRITC secondary antibody (1:50; Dako).
RT-PCR assay. Total RNA was prepared (Chomzynski and
Sacchi, 1987) from embryoid bodies after 4, 8, 12, and 16 days of
culture, treated with RNase-free DNase I (Boehringer Mannheim),
and resuspended in 20 ml of diethylpyrocarbonate-treated double-
istilled water. Five micrograms of total RNA was converted into
rst-strand cDNA using the Ready-To-Go Kit (Pharmacia), with an
ligo(dT) primer, as per manufacturer instructions. PCR amplifica-
ion was performed using oligonucleotide primers specific for a
umber of cardiac genes as follows (sense and antisense, respec-
ively): Hand1, 59-gcgcctggctaccagttaca-39 and 59-agcaacgccttccc-
ctagg-39, which yield a 794-bp product; Nkx2-5, 59-cacaccc-
cgcctttctcag-39 and 59-ctgcgtggacgtgagcttca-39, which yield a prod-
ct of 520 bp; a-cardiac actin (aCA), 59-agagtatgatgaggcaggcc-39
nd 59-atgactgatgagagatgggg-39, which yield a 110-bp product;
LC2a, 59-gcagccaccaagcaggcaca-39 and 59-ccccgaagagtgtgaggaag-
39, which yield a 250-bp product; MLC2v, 59-tgttcctcacgatgtttggg-39
and 59-ctcagtccttctcttctccg-39, which yield a 260-bp product; ANF,
59-aagatgaggtcatgcccccg-39 and 59-atcttcgtaggctccgaggg-39, which
ield a 220-bp product; SM22a, 59-atgggcagcaacagaggagc-39 and
59-gtacagctgggaacaggggc-39; ErbB2, 59-ggatgatgacatgggggagc-39 and
59-gaggtcatgtggagagaggc-39, which yield a 289-bp product; ErbB4,
59-aggaatatttggtcccccag-39 and 59-aaacatctcagccgttgcac-39, which
yield a 200-bp product; and b-actin (Lyons et al., 1995). PCRs were
performed on a PTC-100 thermal controller (MJ Research) using 1
ml of cDNA, 1 mM each oligonucleotide primer, and 1 Unit of Taq
olymerase (Promega) in 50 ml of buffer (50 mM KCl, 10 mM
Tris–HCl at pH 8.3, 1.5 mM MgCl2, 200 mM dNTPs). PCR cycles
were as described by Lyons et al. (1995). PCR products were
electrophoresed on 1.5% agarose gels containing ethidium bromide
and photographed. Semiquantitative RT-PCR was carried out on
day 12 embryoid bodies for MLC2v using progressive fivefold serial
dilutions of RT cDNA template (amplified for 30 cycles) and by
reducing the cycle number from 30, at 5-cycle increments.
e
r
Copyright © 2000 by Academic Press. All rightGeneration and analysis of chimeric embryos. ROSA26 mice
bearing a ubiquitously expressed b-galactosidase transgene on a 129
train background (Friedrich and Soriano, 1991) were obtained from
ackson Laboratories. Eight-cell stage ROSA26 embryos were ag-
regated with ES cells using the morula aggregation technique as
escribed previously (Nagy et al., 1993). Aggregates were cultured
overnight at 37°C and resulting blastocysts transferred into the
uteri of pseudopregnant CD-1 females. Chimeric embryos were
dissected between E7.5 and E10.5 and the contribution of mutant
ES cells and wild-type ROSA26 cells to the embryo was determined
by whole-mount b-galactosidase staining. Chimeric embryos were
stained for b-galactosidase activity with X-gal according to the
ethod described previously (Ciruna et al., 1997). Stained embryos
ere photographed and then embedded in paraffin and sectioned at
mm. Sections were counterstained with 0.5% eosin. The propor-
tion of blue (wild type) and white (mutant) cells in different regions
of moderate-contribution (approximately 50%) chimeras selected
at random was scored on nonadjacent serial coronal and sagittal
sections. The data were tabulated and analyzed using unpaired
Student’s t test, assuming unequal variance.
In situ hybridization. Whole-mount in situ hybridization was
performed on wild-type embryos as described by Conlon and
Rossant (1992). The Hand1 probe was generated from a full-length
cDNA (Cross et al., 1995).
RESULTS
Hand1-null ES cells differentiate into cardiomyocytes in
vitro. To define the functions of Hand1 during early heart
evelopment we disrupted both alleles of the gene by
equential homologous recombination events in R1 ES cells
Nagy et al., 1993). The first round of targeting (Riley et al.,
998) resulted in the vector PGKneor replacing proximal 59
promoter sequences, exon 1, the single intron, and part of
exon 2 to produce the null allele Hand1neo (Fig. 1A). To
arget the second allele we used an alternative vector,
ucPGKpuror, to replace exon 1, which encodes the bHLH
domain, and produce the null allele Hand1lp (Fig. 1A). Two
Hand1-null ES cell lines were isolated (lines 6.13 and 6.22).
Three control lines that contained single-copy, random
insertions of the lucPGKpuror targeting vector were also
isolated (lines 1.22, 5.13, and 6.39; data not shown). During
culture in the absence of LIF, all ES cell lines formed
floating embryoid bodies. There was no difference between
embryoid bodies of different genotype in their size or gross
morphology, based on H&E-stained sections (Fig. 2A). Cavi-
tation of the embryoid bodies occurred in all lines after
prolonged culture (10–16 days), though at a slightly reduced
rate in Hand1-null lines (20% reduction).
To determine if ventricular cardiac lineage commitment
and cardiomyocyte differentiation were defective in Hand1
utant cells, we set up adherent cultures of differentiating
S cell lines; beating cardiomyocytes can be more reliably
een and scored in adherent cultures and a high percentage
f wild-type embryoid bodies grown under these conditions
ontain cardiomyocytes (Narita et al., 1996). When differ-
ntiated as adherent cultures, single or multiple foci of
hythmically beating cardiac muscle cells were observed at
s of reproduction in any form reserved.
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Embryo 100% derived from ES cells. (C, D) Embryo derived from
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Copyright © 2000 by Academic Press. All rightthe same time (beginning after 7 days in culture) and
occurred at the same rate in the Hand1-null lines (6.13 and
6.22) compared to controls (data not shown). Approximately
20% of cells were beating after 10 days in culture, and this
increased to approximately 50% after 16 days. To confirm
that beating cells within floating embryoid bodies were
cardiomyocytes, we carried out immunofluorescence mi-
croscopy with the MF20 monoclonal antibody to detect
cardiac myosin (Bader et al., 1982). Sections through day 10
and 14 control and Hand1-null embryoid bodies that had
contained contracting cells also expressed cardiac myosin
(MF20) immunoreactivity (Fig. 2B). The MF20 staining
pattern was either punctate, localized to small numbers of
foci, or more diffuse and detectable in a larger number of
myocytes (Fig. 2B). There were no differences in the per-
centage of MF20-positive bodies or the pattern of staining in
either category between control (37% positive; lines 5.13
and 6.39 data pooled) or Hand1-null (35% positive; lines
6.13 and 6.22 data pooled) embryoid bodies.
To analyze myogenesis further, we examined the expres-
sion of cardiac-specific transcripts in Hand1-null embryoid
bodies using RT-PCR analysis (Fig. 2C). Total RNA was
extracted from adult heart and E10.5 placenta as controls
and from embryoid bodies after 4, 8, 12, and 16 days of
differentiation. Hand1 primers were used to confirm an
absence of mRNA in the Hand1-null embryoid bodies and
cytoskeletal b-actin primers were used to normalize the
mount of input cDNA. As shown in Fig. 2C, expression of
and1 in control bodies was first detectable at low levels
fter 6 days of differentiation (data not shown) prior to the
nset of expression at day 8 (Fig. 2C). Nkx2-5 expression
receded that of Hand1, detectable at low levels in both
ontrol and mutant bodies after 4 days in culture, consis-
ent with the idea that Nkx2-5 may function upstream of
and1 (Olson and Srivastava, 1996; Biben and Harvey,
997; Riley et al., 1998). The chamber-specific myofilament
genes MLC2a and MLC2v were examined to confirm the
presence of atrial and ventricular precursors. MLC2a and
MLC2v transcripts were first detected after 4 and 8 days of
culture, respectively, preceding cardiomyocyte contraction,
and their appearance was unaffected in Hand1 mutant
cultures. The failure to see a change in MLC2v transcript
approximately 60% ES cells. Note that cardiac development is
normal in these embryos (B, D) and that there is random mixing of
wild-type and heterozygous cells in the heart (D). (E, F) Phenotypi-
cally normal chimeras derived from Hand1-null ES cells, with
,40% mutant cell contribution, recovered at E9.5 (F) and E10.5 (E)
show exclusion of mutant cells from the left ventricle (lv) and
outflow tract (ot) of the heart, first branchial arch (ba), and limb bud
(lb). (G) Hand1 mRNA expression in E10.5 embryos detected by
whole-mount in situ hybridization. (H, I) Hand1 mRNA expression
in dissected heart from E10.5 embryo, viewed on the left side (H)FIG. 5. Hand1 mutant cells are excluded from a number of
mbryonic tissues in chimeras with moderate ES cell contribution
t E9.5 and E10.5. (A–D) E9.5 chimeras derived from controland anterior surface (I). lv, left ventricle; ba, first branchial arch; lb,
limb bud.
s of reproduction in any form reserved.
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163Role of Hand1 in Cardiac Morphogenesisexpression was verified using semiquantitative RT-PCR
(data not shown). The myofilament gene aCA, the vasoac-
tive gene ANF, and calponin-related gene SM22a were
examined since, like Hand1, they are believed to be down-
stream in the Nkx2-5 molecular pathway (Chen and
Schwartz, 1996; Durocher et al., 1996; Harvey et al., 1999).
Transcripts for aCA, ANF, and SM22a were detected at all
time points in Hand1 mutant bodies at levels comparable
to controls (Fig. 2C). ErbB2 and ErbB4 were examined since
n neural and cardiac lineages they are thought to regulate
ell proliferation and differentiation and in both ErbB2 and
FIG. 6. Exclusion of Hand1-null cells from distinct regions of the
E9.5 chimeric embryos stained for b-galactosidase activity viewed
A) Left lateral view and midsagittal section through left ventricle
ransverse sections through the surface of the left ventricle (middle
urvature of the left ventricle is composed entirely of blue (wild-typ
eficiency of mutant cells in the myocardium (my), outflow tract (o
n the E9.5 heart shown in whole mount (left lateral and ventral v
underdeveloped to highlight the fact that Hand1 is most highly
ventricular myocardium (my) and in the outflow tract (ot).rbB4 homozygous mutant mice there is impaired ventric-
lar myocardial trabeculation (Lee et al., 1995; Gassman et s
Copyright © 2000 by Academic Press. All rightal., 1995) similar to that observed in tetraploid-rescued
Hand1-null mice (Riley et al., 1998). Expression of both
ErbB2 and ErbB4 was detected in both control and mutant
bodies at all time points studied (Fig. 2C). These data
demonstrated that cardiomyocyte differentiation was not
obviously affected by the Hand1 mutation, suggesting that
the thin ventricular wall and down-regulation of MLC2v
observed in tetraploid-rescued Hand1-null embryos (Riley
et al., 1998) were likely secondary to other defects in the
conceptuses.
Since a number of bHLH transcription factors autoregu-
cardium and outflow tract of the looped heart. (A, B) Hearts from
hole-mount or as histological sections counterstained with eosin.
ed area shown at higher magnification). (B) Ventral view and two
deeper region (right) of the embryo in Fig. 5F. Note that the outer
lls. Serial sagittal sections show a relative underrepresentation and
ericardium (pc), and epicardium (ep). (C) Hand1 mRNA expression
) and in transverse section. Note that the in situ hybridization is
ressed in the anterior portion of the outer curvature of the leftmyo
as w
(box
) and
e) ce
t), p
iewslate their expression, we investigated whether Hand1 tran-
cription was affected by inactivation of the gene. The
s of reproduction in any form reserved.
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164 Riley et al.luc-puro targeting construct enabled us to measure lucif-
erase activity driven by the Hand1 locus in the correctly
targeted 6.13 and 6.22 mutant ES cell lines. Luciferase
activity increased significantly from 4 to 16 days of differ-
entiation, in a pattern that recapitulated the endogenous
pattern of Hand1 expression (data not shown). This sug-
gested that Hand1 does not regulate its own transcription.
Interestingly, luciferase activity was undetectable at all
time points in the 5.13 and 6.39 cell cultures, which
contain random insertions of the luc-puro construct.
Hand1-null ES cell-derived embryos have unlooped
hearts. To investigate the role of Hand1 in vivo we
produced chimeras derived from Hand1-null ES cells aggre-
gated with ROSA26 embryos, which ubiquitously express
lacZ (Friedrich and Soriano, 1991). Embryos at various ages
(between E8.0 and E10.5) were stained for b-galactosidase
activity to determine the relative wild-type and mutant cell
contributions to different cell lineages. Chimeras showed
great variations in the extent of ES cell contribution,
ranging from 30 to 100%, as estimated by b-galactosidase
staining. Notably, there were no apparent differences be-
tween chimeras produced using either of the two homozy-
gous ES cell lines (6.13 and 6.22). Chimeric embryos dis-
sected around E8.5 that were entirely derived from Hand1-
null cells (n 5 22) resembled Hand1 homozygous mutant
mbryos (Riley et al., 1998; Figs. 3A and 3B). These embryos
ad failed to turn and had open neural tubes, small somites,
nlooped hearts, and hemorrhagic visceral yolk sacs (Fig.
C). The latter finding was interesting and, because ES cells
o not contribute to yolk sac endoderm, it implies that the
olk sac phenotype in Hand1 mutants is due to a defect(s)
n the extraembryonic mesoderm.
Chimeric embryos dissected at E9.5 and 10.5 that showed
lose to 100% mutant cell contribution resembled null
utants at E8.5, indicating that these high contribution
himeras fail to progress beyond this phase of development.
ome embryos dissected at E10.5 that had reduced mutant
S cell contribution (60–70%) were turned but they were
TABLE 1
Summary of Restricted Contributions of Mutant Cells to Selected
Embryonic
stage
No. embryos
studied
Embryos sho
LHT
(caudal) LV B
E8.0 4 4 (100%) — 0
E8.5 6 — 6 (100%) 0
E9.5 30 — 30 (100%) 0
E10.5 15 — 15 (100%) 0
Note. LHT—linear heart tube; LV—left ventricle; BC—bulbus co
T—neural tube; FB—forebrain.
a Presumptive BC and OT.maller than their littermates (n 5 10). Their heart tubes
ere very abnormal: they bulged out from the embryo but
Copyright © 2000 by Academic Press. All rightemained in the midline, showed no overt left–right asym-
etry or segmentation, and had a thin, transparent wall
Figs. 3D–3F). In these high ES cell contribution chimeras,
ny wild-type cell contribution to the heart tubes was
estricted to small patches that were obviously insufficient
o rescue the cardiac defects. One example is shown in Figs.
D–3F in which a reasonable patch of wild-type cell contri-
ution to the right side of the heart tube was still associated
ith a thin, unlooped heart. These heart tubes, therefore,
esembled those previously observed in tetraploid-rescued
and1-null embryos (Riley et al., 1998). In contrast to
himeras made from the Hand1-null cells, embryos derived
rom the control heterozygous ES cell line (1.22) developed
ormally (Figs. 5A and 5B).
Hand1 mutant cells show deficiencies in contribution to
art of the left ventricular myocardium in low-
ontribution chimeras. Chimeric embryos with approxi-
ately 50% mutant ES cell contribution, or less, were able
o develop normally (Figs. 4 and 5). Chimeric embryos with
pproximately 50% mutant ES cell contribution at the E8.0
tage (prior to looping; n 5 4) displayed a nonrandom
istribution of cells in the heart tube (Table 1). Mutant cells
b-galactosidase-negative) were underrepresented in the
caudal region of the heart tube (Figs. 4C–4E), a region where
Hand1 is expressed at this early stage (Fig. 4B) and which is
fated to become the left ventricle. Notably, however, the
mutant cells were most prominently restricted from the left
side of this caudal region (Figs. 4C–4G; Table 1). We did not
observe chimeras in which this restriction occurred bilat-
erally or exclusively on the right side, despite the fact that
Hand1 is bilaterally expressed at this early stage (Biben and
Harvey, 1997; Fig. 4B). There also appeared to be a greater
proportion of wild-type cells on the ventral surface of the
heart tube in some embryos, again consistent with the
major site of Hand1 expression. In chimeric embryos at the
E8.5 stage with looped heart tubes (n 5 6), the outer surface
of the left ventricle was largely derived from wild-type cells
and appeared to largely exclude mutant cells, whereas
ons of Chimeras
reduced contribution of mutant (white) cells
OT LB LPM
NT
(dorsal) FB
2a (50%) — — — —
4 (67%) — 5 (83%) — 0
22 (73%) 25 (83%) 18 (60%) 27 (90%) 0
12 (80%) 15 (100%) 9 (60%) 13 (87%) 0
OT—outflow tract; LB—limb bud; LPM—lateral plate mesoderm;Regi
wing
C
a
rdis;mutant cells were apparent in other regions of the heart
(Figs. 4K–4M; Table 1). Chimeras at E9.5 (n 5 30) and 10.5
s of reproduction in any form reserved.
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165Role of Hand1 in Cardiac Morphogenesis(n 5 15) consistently revealed a deficiency of mutant
(b-galactosidase negative) cells in the left ventricle but not
in other chambers of the heart such as the bulbus cordis or
control regions of the embryo such as the forebrain (Figs. 5F,
6A,and 6B; Table 1). These findings are consistent with
Hand1 expression at these stages (Figs. 5G–5I and 6C). In
ontrast, the control heterozygous ES line (1.22) was able to
istribute randomly to all tissues (Figs. 5C and 5D; data not
hown).
To further investigate the distribution of mutant cells
ithin chimeras, phenotypically normal E9.5 chimeric em-
ryos (n 5 20) were examined histologically. Representa-
tive whole mount and sagittal and transverse sections
through the developing hearts of individual chimeras are
shown in Figs. 6A and 6B. Independent regions of mutant
cell origin were evident in the myocardium, although
sparsely distributed, of the ventricular wall and in the
trabeculated layer of myocardium that projects into the
ventricular lumen (Figs. 6A and 6B). This demonstrated that
Hand1-null ES cells are able to differentiate into cardiomy-
ocytes in vivo. However, in moderate contribution chime-
ras we observed an underrepresentation of mutant cardio-
myocytes in some regions of the myocardium (Fig. 6B). The
relative proportion of blue and white cells in different
regions of the myocardium was evaluated by scoring all
myocardial cells on four nonadjacent serial sections from
each of several moderate-contribution chimeras selected at
random (40–60 cardiomyocytes per section; Table 2). In
coronal sections of chimeric embryos (n 5 3 embryos),
TABLE 2
The Number of Blue (WT) and White (Mutant) Cells in Different R
Embryoc
Coronal sections
LV outer
curvature
BC outer
curvature
Blue
(WT)
White
(mutant)
Blue
(WT)
White
(mutant)
47d 10.5 12 28.25
2 69 5 19 28.5
3 46.25 3.75 15.25 29.75
Mean 54.08 6.42 15.42 28.17
Mean % of total 89 11 35 65
SEM 5.57 1.54 1.20 1.56
t 2.16 2.08
P ,0.001 ,0.001
Note. LV—left ventricle; BC—bulbus cordis; t—unpaired t test a
ersus mutant cells in specified cardiac region occurred by chance
a Distal to the common atrial chamber.
b Proximal to the common atrial chamber.
c Representative chimeras selected at random.
d Mean cell count taken from 4 serial sections per chimera.whereas the outer curvature of the bulbus cordis contained
only 35% wild-type (blue) cells and 65% mutant cells, the
Copyright © 2000 by Academic Press. All rightouter curvature of the left ventricle contained 89% wild-
type cells (P , 0.001). In sagittal sections through the left
ventricle of moderate-contribution chimeras (n 5 3 em-
bryos; Table 2), the wild-type:mutant cell ratio was 75%:
25% in the anterior face of the outer curvature but only
21%:79% in the posterior face (P , 0.001). These data
were representative of the entire cohort of phenotypically
normal chimeras examined at E9.5 (n 5 20) and indicate
that by E10.5, Hand1-null cells become excluded from the
anterior portion of the outer curvature of the left ventricle,
coinciding with the region of maximal Hand1 expression
(Fig. 6C).
Deficiency of Hand1 mutant cell contribution to other
mesodermal and neural crest-derived tissues. In addition
to the ventricular myocardium, Hand1 mutant cells were
observed less frequently in E9.5 and 10.5 embryos in the
branchial arches (Figs. 5E, 5F, and 7D) and dorsal root
ganglia (data not shown), both of which are neural crest
derived. There were no L/R differences observed in the
distribution of cells (data not shown). Mutant cells were
also excluded from the dorsal neuroepithelium, as well as
several mesodermal populations such as in the limb bud,
lateral mesoderm, and somites (Fig. 7; Table 1). Hand1-null
cells were also underrepresented in the pericardium (Figs.
6A and 6B; Table 2) and outflow tract (Figs. 6B and 7C;
Table 1) of the heart. The smooth muscle and connective
tissue of the outflow tract and great vessels are formed in
part by cardiac neural crest cells that arise from the dorsal
neuroepithelium in the postotic hindbrain (Kirby, 1993).
ns of Myocardium in Coronal and Sagittal Sections
Sagittal sections
LV anterior-
distala
LV posterior-
proximalb Pericardium
lue
T)
White
(mutant)
Blue
(WT)
White
(mutant)
Blue
(WT)
White
(mutant)
6.25 11.75 9.25 29 26.75 3.25
4.5 14.75 8.5 26.5 16 7
7.5 16.5 8.5 42.5 27.75 8.75
2.83 14.33 8.75 32.67 23.5 6.33
5 25 21 79 79 21
4.42 1.20 0.62 2.51 2.08 1.02
2.16 2.18 2.13
,0.001 ,0.001 ,0.001
ing unequal variance; P—probability that distribution of wild-typeegio
B
(W
4
2
5
4
7
ssum
.This region also contributes neural crest cells that migrate
to the first branchial arch. Histological sections in this
s of reproduction in any form reserved.
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166 Riley et al.region showed a consistent deficiency of mutant cells in
neural tube, particularly in the dorsal half (Figs. 7D–7F).
DISCUSSION
Hand1 has many roles during mouse development.
and1-deficient embryos arrest at around E8.0 of develop-
ent with extraembryonic defects including a deficiency of
rophoblast giant cells and abnormal yolk sacs (Firulli et al.,
1998; Riley et al., 1998; Scott et al., 2000). Tetraploid-
rescued Hand1-null embryos can develop further but die
around E10, associated with a failure in cardiac looping and
segmentation of the heart tube and a severe reduction in
FIG. 7. Hand1-null cell exclusion from pre- and postmigratory
populations of neural crest. (A–C). Sagittal sections through a
representative E9.5 chimera. (D) Cross section through a represen-
tative E9.5 chimera. High-magnification views of the dorsal (E) and
ventral (F) parts of the neural tube cut in cross section are shown for
comparison. Note the deficiencies of mutant (pink) cells from the
premigratory cells in the dorsal neural tube (nt) and somites (so)
and in the posterior mesencephalic and anterior rhombencephalic
neural crest of the developing mid- and hindbrain (mb, hb). Hand1-
null cells are also excluded from regions in the postmigratory
neural crest-derived branchial arch (ba) mesenchyme and cardiac
outflow tract (ot).myocardial wall thickness (Riley et al., 1998). In this study
we have tested the developmental fate of Hand1-null ES
Copyright © 2000 by Academic Press. All rightcells to dissect these cardiac phenotypes and address the
primary functions of Hand1 in heart development. We
conclude that cardiomyocyte proliferation and differentia-
tion can proceed normally in Hand1-deficient cells. None-
theless, chimeric embryo analysis revealed that Hand1 is
required cell autonomously in a subset of cardiac mesoder-
mal derivatives that contribute to the outer curvature of the
left ventricle. The exclusion patterns of mutant cells in
chimeras revealed that Hand1 is also critical for develop-
ment of several other tissues, including the neural tube,
somites, branchial arches, and cardiac outflow tract.
This study revealed a striking exclusion of Hand1-null
cells from the outer curvature of the left ventricle that was
apparent by E8.5. There are several potential explanations
for this finding. Mutant cells may have initially colonized
these regions but subsequently either failed to proliferate or
underwent cell death. Cell death is not an obvious feature
of Hand1 mutant embryos, but has been suggested as a
mechanism for cardiac defects in Hand2 mutants (Yama-
gishi et al., 1999). Alternatively, Hand1-null mutant cells
may have been segregated from the precursors of these
myocardial populations at an earlier stage of development.
We favor the latter hypothesis because at E8.0, Hand1-null
cells were excluded from the left-caudal region of the linear
tube. The mechanism by which mutant cells are excluded
from this region is unknown. We have examined chimeras
at E7.5 and observed only random mixtures of mutant and
wild-type cells in the cardiac crescent (P.R. and J.C.C.,
unpublished observations), and so the rearrangement must
occur within a narrow time frame. The fate of Hand1 null
cells would be best addressed by studying the fate of mutant
cells in real time in cultured embryos using video micros-
copy.
Two models have been previously proposed for the func-
tion of Hand1 during early development of the heart tube.
On the one hand, it has been proposed that Hand1 and
Hand2 have a role in “specification” of the two ventricles
based on the reciprocal expression patterns of these two
factors in the left and right ventricles of mouse embryos,
respectively (Srivastava et al., 1995). The fact that the
hearts in Hand2 mutant embryos lack a recognizable right
ventricular chamber, resulting in a direct connection be-
tween a left ventricle and the outflow tract (Srivastava et
al., 1997), is cited as support of this model (Srivastava et al.,
1999). While it is possible that Hand1 has a comparable role
in growth or maintenance of the left ventricle, this model
does not satisfactorily explain Hand1 function because it
does not account for three important observations. First,
Hand1 is expressed in only part of the presumptive left
ventricle in the early heart tube (the anterior surface of the
outer curvature) as it forms (Biben and Harvey, 1997;
Thomas et al., 1998). This, therefore, begs the question as to
what would “specify” the rest of the left ventricle. Second,
the model does not account for the fact that the heart tube
does not loop in Hand1 mutant embryos and remains at a
primitive stage of development (Riley et al., 1998). In other
words, the phenotype is not simply an absence of the left
s of reproduction in any form reserved.
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167Role of Hand1 in Cardiac Morphogenesisventricle. Third, we observe no defects in the ability of
Hand1 myocardial cells to differentiate into ventricular
ardiomyocytes in vivo, in vitro, or in chimeras. MLC2v
xpression is detectable, albeit weakly, in the cardiac cres-
ent of Hand1 mutant embryos (Riley et al., 1998; Firulli et
al., 1998) and we found no change in MLC2v mRNA
expression in differentiating embryoid bodies. In chimeras,
Hand1-null cells were able to contribute to the right
ventricle as well as the posterior surface and inner curva-
ture of the left ventricle. Together these findings indicate a
function for Hand1 during cardiac looping unrelated to the
control of ventricular myocardial differentiation.
A second model is that Hand1 plays a primary role in
cardiac looping morphogenesis, perhaps unrelated to a role
in formation or maintenance of the left ventricle. This was
proposed based upon the circumstantial evidence that the
site of Hand1 expression, in the outer curvature of the left
ventricle, is thought to be the leading edge of the looping
heart tube (Taber et al., 1995; Biben and Harvey, 1997). This
odel is attractive because it accounts for the restricted
xpression pattern and is clearly supported by the failure in
ooping in Hand1 mutant embryos (Riley et al., 1998). In
ddition, the failure of cardiac looping in Nkx2-5 mutant
embryos (Lyons et al., 1995) can be explained by the loss of
Hand1 expression (Biben and Harvey, 1997). Hand1 is
nitially bilaterally expressed at the caudal end of the early
inear heart tube (Srivastava et al., 1995; Thomas et al.,
998). However, its expression is reported to become asym-
etrical and biased toward the left side at the late linear
tage and with the onset of looping in both the mouse
Biben and Harvey, 1997) and the frog (Sparrow et al., 1998).
his latter finding has been disputed in the mouse (Thomas
t al., 1998). Nonetheless, the fact that Hand1 expression is
imited to a portion of the left ventricle later in develop-
ent indicates that its expression eventually becomes
estricted. Our chimera studies directly addressed this is-
ue. While only a relatively small number of embryos were
nformative, we observed in moderate-contribution chime-
as at the linear heart tube stage a consistent and preferen-
ial exclusion of Hand1 mutant cells from the left side of
he linear tube. Clearly, because the L/R restriction at the
inear heart tube stage has been attributable to only a small
ohort of chimeric embryos to date, it is worthy of further
nalysis. Nonetheless, this finding is consistent with the
bserved exclusion of mutant cells from only a part of the
uter curvature (the anterior face) after looping is com-
leted. The implication of this finding is that while it may
e expressed bilaterally, Hand1 function may not be re-
quired bilaterally. The pathways controlling L/R laterality
(Harvey, 1998) and looping morphogenesis clearly intersect
at some level. It may be that genes required for initiating
the morphogenesis of looping, such as Hand1, are initially
ilaterally expressed to allow the heart to potentially loop
n either direction, depending on the L/R signals received to
ictate the direction of looping. Under normal circum-
tances, this would mean that its function in the linear tube
ight be limited to the left side. Exclusion of mutant cells
Copyright © 2000 by Academic Press. All rightrom this region, in anticipation of the onset of looping,
uggests a cell-autonomous requirement for Hand1 func-
ion at the initiation of looping.
The underlying mechanism of cardiac looping is un-
nown, although several studies have suggested that
hanges in cell shape, cell–cell interaction, and/or cell
igration occur in the heart tube coincidentally with
ooping (Tsuda et al., 1996; Smith et al., 1997). The deter-
ination of downstream target genes for Hand1 will assist
n resolving if factors involved in these processes lie in the
and1 molecular pathway. The generation of Hand1 ho-
ozygous mutant ES cells and the in vitro differentiation
ssay described here provide us with the tools to explore
his important area of study.
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